tiprankstipranks
Advertisement
Advertisement
Altimmune Bets Big on PEMB as Phase III Nears
PremiumCompany AnnouncementsAltimmune Bets Big on PEMB as Phase III Nears
1M ago
Altimmune price target lowered to $13 from $18 at B. Riley
Premium
The Fly
Altimmune price target lowered to $13 from $18 at B. Riley
1M ago
Altimmune reports Q4 EPS (27c), consensus (24c)
Premium
The Fly
Altimmune reports Q4 EPS (27c), consensus (24c)
1M ago
Altimmune initiated with a Buy at Titan Partners
PremiumThe FlyAltimmune initiated with a Buy at Titan Partners
2M ago
Short Report: VNET Group short interest at 4-month high
Premium
The Fly
Short Report: VNET Group short interest at 4-month high
2M ago
Altimmune Sets 2026 Annual Stockholder Meeting Timeline
Premium
Company Announcements
Altimmune Sets 2026 Annual Stockholder Meeting Timeline
2M ago
Altimmune initiated with an Overweight at Barclays
PremiumThe FlyAltimmune initiated with an Overweight at Barclays
3M ago
Altimmune call volume above normal and directionally bullish
Premium
The Fly
Altimmune call volume above normal and directionally bullish
3M ago
Unusually active option classes on open January 22nd
Premium
The Fly
Unusually active option classes on open January 22nd
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100